A new study supported by NHS Grampian is helping protect people at higher risk of cervical cancer* - and it’s doing things a little differently.
The HPV Equity Study is offering the HPV vaccine and testing to communities who may not usually take part in routine cervical screening. This includes women, trans men, and non-binary people who have experienced homelessness, substance misuse, contact with sex industry, addiction, or time in prison.
What makes this study special is where it’s happening. Led by the NHS Grampian Sexual Health team the study is being run in community settings and includes HMP Grampian Prison. Our research nurses Fiona and Amanda are working with the HMP Grampian Prison nurse to identify and recruit patients to this study. This collaboration could pave the way for future studies taking place in this setting.
The study is looking at how acceptable it is to offer HPV vaccination and testing during sexual health appointments. It also asks people about their experiences and what could make vaccination more accessible in the future. More information can be found here: https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/hpv-equity-study/
This work is important because HPV (human papillomavirus) can lead to cervical cancer, and some people are more at risk than others. But they may also face more barriers to accessing care.
By reaching people where they are, this study shows the dedication and flexibility of the teams involved. It’s a great example of how healthcare can adapt to meet everyone’s needs.